The following Corporation Tax guidance note Produced by Tolley provides comprehensive and up to date tax information covering:
There are several steps which must be carried out in order to calculate the amount of qualifying IP profits to which the reduced patent box rate of corporation tax can be applied. Please read the Calculating relevant IP profits ― from 1 July 2016 guidance note in conjunction with this note for further details of these steps.
For new entrants to the patent box regime, broadly those making their first election for an accounting period beginning on or after 1 July 2016, Step 6 requires the calculation of an R&D fraction. This is sometimes referred to as the ‘nexus fraction’ and effectively limits the level of profits that are eligible for the patent box rate. This is a requirement arising from the OECD’s report on preferential IP regimes and was introduced by FA 2016, s 64.
This fraction is based on the amount of qualifying in-house R&D expenditure incurred by the patent box company on that particular patent (or other qualifying IP right) plus third party sub-contracted R&D, relative to overall R&D expenditure and any relevant IP acquisition costs. A separate nexus fraction will have to be calculated under this regime for each stream of qualifying patent box profits based on R&D expenditure incurred on the specific patent to which the income stream relates.
The way in which the R&D fraction is calculated for a relevant IP income sub-stream is set out below.
Changes which impact the calculation of the R&D fraction have been introduced by F(No 2)A 2017, s 23. The amendments seek to ensure that companies sharing income and costs of R&D projects under CSA are neither advantaged nor disadvantaged for the purposes of the patent box. Commercial arrangements such as this had previously been excluded from the patent box legislation. The intended result of these changes is that the company’s own contribution to the development work should drive the amount of profit benefitting from the reduced patent box rate, rather than the
**Free trials are only available to individuals based in the UK. We may terminate this trial at any time or decide not to give a trial, for any reason.
Access this article and thousands of others like it free for 7 days with a trial of TolleyGuidance.
Read full article
Already a subscriber? Login
If an individual sells a chargeable asset and makes an allowable loss, how can this be relieved?First of all, since the simplification of capital gains tax from 6 April 2008, the proforma to calculate a loss is the same as the proforma to calculate a gain. See the Basic calculation principles of
Liability of the personal representativesAfter a person’s death, the property of the deceased is vested in the personal representatives (PRs) to enable them to manage and distribute the estate in accordance with the Will or the terms of intestacy. See the Personal representatives guidance note.The
Statutory sick pay (SSP)Statutory sick pay has its origins in the Social Security and Housing Benefits Act 1982, Part 1. Various amendments have been made to this Act to give us the SSP system we now operate.Temporary changes to SSP for coronavirus (COVID-19)New legislation has been put in place in
Interest paid on qualifying loans is deducted from the taxpayer’s total income (ie a Step 2 deduction from total income). See the Proforma income tax calculation guidance note.Interest on qualifying loans is usually paid gross by the individual borrower; tax is not withheld at source. This includes
To view our latest tax guidance content, sign in to Tolley Guidance or register for a free trial.